Nation-Wide Analysis of Glaucoma Medication Prescription in Fiscal Year of 2019 in Japan
To report the updated prescription trend of antiglaucoma medications, the dose-based prescription of a glaucoma medication in Japan in the fiscal year 2019 was aggregated by using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open data. Of the 100 most...
Main Author: | Masaki Tanito |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/6/956 |
Similar Items
-
Myopic Shift After the Administration of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
by: Kenji Inoue, et al.
Published: (2023-01-01) -
Screening of the Drug-Induced Effects of Prostaglandin EP2 and FP Agonists on 3D Cultures of Dexamethasone-Treated Human Trabecular Meshwork Cells
by: Megumi Watanabe, et al.
Published: (2021-07-01) -
Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
by: Soma Suzuki, et al.
Published: (2022-03-01) -
Cystoid macular edema associated with omidenepag isopropyl in a phakic eye with an implantable collamer lens: a case report
by: Byung-Jin Bae, et al.
Published: (2023-07-01) -
Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma
by: Sumita Mohapatra, et al.
Published: (2023-01-01)